Literature DB >> 31485902

Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation Prior to Abdominal Operation: a Retrospective Analysis.

Adam Schmitz1,2, Paul Haste3, Matthew S Johnson3.   

Abstract

PURPOSE: Transjugular intrahepatic portosystemic shunt (TIPS) creation is most commonly performed for patients with refractory ascites or variceal hemorrhage. While TIPS have also been created prior to planned abdominal operation to decrease morbidity related to portal hypertension, there are limited data supporting its effectiveness in that indication. The goal of this study was to determine if preoperative TIPS creation allows for successful abdominal operation with limited morbidity.
METHODS: A retrospective review of records of 22 consecutive patients who underwent TIPS creation for the specific indication of improving surgical candidacy, between 2011 and 2016, was performed. Clinical and serologic data were obtained for 21 patients (one patient was excluded since she was completely lost to follow-up after TIPS creation). The primary endpoint was whether patients underwent planned abdominal operation following TIPS. Operative outcomes and reasons that patients failed to undergo planned operation were examined as secondary endpoints. The mean age was 56.4 ± 8.8 years and the mean Child-Pugh and Model for End-Stage Liver Disease (MELD) scores were 7.2 ± 1.5 and 11.9 ± 4.3, respectively.
RESULTS: TIPS creation was performed in all 21 patients with a 30-day mortality rate of 9.5%. Eleven patients (52.4%) subsequently underwent abdominal operation after which the 30-day postoperative mortality rate was 0%. One patient (9.1%) had major perioperative morbidity related to portal hypertension and presented with surgical wound dehiscence and infection requiring drain placement and antibiotic therapy.
CONCLUSIONS: In this population, TIPS allowed successful abdominal operation in the majority of patients, with 30-day TIPS mortality of 9.5%, no perioperative mortality, and 9.1% major postoperative morbidity attributable to portal hypertension.

Entities:  

Keywords:  Portal hypertension; Surgery; TIPS; Transjugular intrahepatic portosystemic shunt

Mesh:

Year:  2019        PMID: 31485902      PMCID: PMC7416631          DOI: 10.1007/s11605-019-04384-w

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  15 in total

Review 1.  Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.

Authors:  Oliviero Riggio; Silvia Nardelli; Federica Moscucci; Chiara Pasquale; Lorenzo Ridola; Manuela Merli
Journal:  Clin Liver Dis       Date:  2012-01-04       Impact factor: 6.126

2.  Neoadjuvant transjugular intrahepatic portosystemic shunt: a solution for extrahepatic abdominal operation in cirrhotic patients with severe portal hypertension.

Authors:  D Azoulay; F Buabse; I Damiano; A Smail; P Ichai; M Dannaoui; D Castaing; H Bismuth
Journal:  J Am Coll Surg       Date:  2001-07       Impact factor: 6.113

Review 3.  Obesity and liver disease: the epidemic of the twenty-first century.

Authors:  Kathleen E Corey; Lee M Kaplan
Journal:  Clin Liver Dis       Date:  2014-02       Impact factor: 6.126

4.  Model for End-Stage Liver Disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis.

Authors:  Patrick G Northup; Ryan C Wanamaker; Vanessa D Lee; Reid B Adams; Carl L Berg
Journal:  Ann Surg       Date:  2005-08       Impact factor: 12.969

5.  Transjugular intrahepatic portosystemic shunt before abdominal surgery in cirrhotic patients: a retrospective, comparative study.

Authors:  Evelyne Vinet; Pierre Perreault; Louis Bouchard; Denis Bernard; Ramses Wassef; Carole Richard; Richard Létourneau; Gilles Pomier-Layrargues
Journal:  Can J Gastroenterol       Date:  2006-06       Impact factor: 3.522

6.  Risk factors for mortality after surgery in patients with cirrhosis.

Authors:  Swee H Teh; David M Nagorney; Susanna R Stevens; Kenneth P Offord; Terry M Therneau; David J Plevak; Jayant A Talwalkar; W Ray Kim; Patrick S Kamath
Journal:  Gastroenterology       Date:  2007-01-25       Impact factor: 22.682

7.  Transjugular intrahepatic portosystemic shunt placement before abdominal intervention in cirrhotic patients with portal hypertension: lessons from a pilot study.

Authors:  Nadim Fares; Marie-Angèle Robic; Jean-Marie Péron; Fabrice Muscari; Philippe Otal; Bertrand Suc; Jean-Pierre Vinel; Christophe Bureau
Journal:  Eur J Gastroenterol Hepatol       Date:  2018-01       Impact factor: 2.566

Review 8.  Morbidity and mortality related to non-hepatic surgery in patients with liver cirrhosis: a systematic review.

Authors:  B de Goede; P J Klitsie; J F Lange; H J Metselaar; G Kazemier
Journal:  Best Pract Res Clin Gastroenterol       Date:  2012-02       Impact factor: 3.043

9.  Surgery in the patient with liver disease.

Authors:  Jacqueline G O'Leary; Patrick S Yachimski; Lawrence S Friedman
Journal:  Clin Liver Dis       Date:  2009-05       Impact factor: 6.126

10.  Cirrhotic patients with a transjugular intrahepatic portosystemic shunt undergoing major extrahepatic surgery.

Authors:  John J Kim; Narasimham L Dasika; Esther Yu; Robert J Fontana
Journal:  J Clin Gastroenterol       Date:  2009-07       Impact factor: 3.062

View more
  3 in total

1.  TIPSS as a bridge to extrahepatic abdominal surgery: a case report.

Authors:  Audrey Pamela Kapeleris; Suresh Venkatachalapathy
Journal:  Oxf Med Case Reports       Date:  2022-04-19

2.  Preoperative TIPS prevents the development of postoperative acute-on-chronic liver failure in patients with high CLIF-C AD score.

Authors:  Johannes Chang; Pauline Höfer; Nina Böhling; Philipp Lingohr; Steffen Manekeller; Jörg C Kalff; Jonas Dohmen; Dominik J Kaczmarek; Christian Jansen; Carsten Meyer; Christian P Strassburg; Jonel Trebicka; Michael Praktiknjo
Journal:  JHEP Rep       Date:  2022-01-21

Review 3.  Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update.

Authors:  Sasidharan Rajesh; Tom George; Cyriac Abby Philips; Rizwan Ahamed; Sandeep Kumbar; Narain Mohan; Meera Mohanan; Philip Augustine
Journal:  World J Gastroenterol       Date:  2020-10-07       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.